Literature DB >> 22098435

Urinary 8-hydroxy-2'-deoxyguanosine level and plasma paraoxonase 1 activity with Alzheimer's disease.

Oğuzhan Zengi1, Alpaslan Karakas, Ufuk Ergun, Mehmet Senes, Levent Inan, Dogan Yucel.   

Abstract

BACKGROUND: Alzheimer's disease (AD) is the most frequent cause of dementia and age is the most important risk factor for AD. Aging is associated with increased free radical production and oxidative stress plays an important role in the pathogenesis of AD. 8-Hydroxy-2'-deoxyguanosine (8-OHdG) is a biomarker indicating oxidative DNA damage. Paraoxonase 1 (PON1) is a high-density lipoprotein (HDL)-associated antioxidant enzyme and prevents especially oxidation of low-density lipoproteins. The aim of this study is to measure urinary 8-OHdG levels and serum PON1 activity in patients with AD.
METHODS: A total of 21 elderly patients diagnosed with moderate AD (10 men and 11 women, aged 76 ± 7.8 years) were included in the study. A total of 20 healthy elderly volunteers (11 men and nine women, aged 81 ± 7.2 years) were enrolled as a control group. Levels of urinary 8-OHdG, serum PON1 activity and lipid profile were determined in patients and controls.
RESULTS: Urinary 8-OHdG levels were significantly increased, but serum PON1 activity was significantly decreased in patients compared to controls. Lipid profile did not show a difference between the groups. There was a negative correlation between 8-OHdG levels and PON1 activity only in the patient group (r=-0.536). Analytical performance characteristics of the methods used were satisfactory.
CONCLUSIONS: In this study, evidence of increased oxidative DNA damage was determined in AD patients as well as decreased serum PON1 activity. Oxidant stress and oxidative DNA damage are important pathological processes in AD. The biomarkers, urinary 8-OHdG level and serum PON1 activity can be used to determine and monitor the status of patients with AD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22098435     DOI: 10.1515/CCLM.2011.792

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  15 in total

Review 1.  Nrf2--a therapeutic target for the treatment of neurodegenerative diseases.

Authors:  Delinda A Johnson; Jeffrey A Johnson
Journal:  Free Radic Biol Med       Date:  2015-08-14       Impact factor: 7.376

2.  Contextualised urinary biomarker analysis facilitates diagnosis of paediatric obstructive sleep apnoea.

Authors:  Lev Becker; Leila Kheirandish-Gozal; Eduard Peris; Kelly Q Schoenfelt; David Gozal
Journal:  Sleep Med       Date:  2014-02-07       Impact factor: 3.492

Review 3.  Evaluating the link between Paraoxonase-1 levels and Alzheimer's disease development.

Authors:  Carlo Cervellati; Giuseppe Valacchi; Veronica Tisato; Giovanni Zuliani; Judit Marsillach
Journal:  Minerva Med       Date:  2018-10-11       Impact factor: 4.806

Review 4.  The Endothelium Is Both a Target and a Barrier of HDL's Protective Functions.

Authors:  Jérôme Robert; Elena Osto; Arnold von Eckardstein
Journal:  Cells       Date:  2021-04-28       Impact factor: 6.600

5.  Interactions between paraoxonase 1 genetic polymorphisms and smoking and their effects on oxidative stress and lung cancer risk in a Korean population.

Authors:  Sang-Yong Eom; Dong-Hyuk Yim; Chul-Ho Lee; Kang-Hyeon Choe; Jin Young An; Kye Young Lee; Yong-Dae Kim; Heon Kim
Journal:  PLoS One       Date:  2015-03-05       Impact factor: 3.240

Review 6.  Oxidative Stress and Its Clinical Applications in Dementia.

Authors:  Peizhong Mao
Journal:  J Neurodegener Dis       Date:  2012-08-30

7.  The NADPH oxidase NOX2 mediates loss of parvalbumin interneurons in traumatic brain injury: human autoptic immunohistochemical evidence.

Authors:  Stefania Schiavone; Margherita Neri; Luigia Trabace; Emanuela Turillazzi
Journal:  Sci Rep       Date:  2017-08-18       Impact factor: 4.379

Review 8.  Potential fluid biomarkers for pathological brain changes in Alzheimer's disease: Implication for the screening of cognitive frailty.

Authors:  Qingwei Ruan; Grazia D'Onofrio; Daniele Sancarlo; Antonio Greco; Zhuowei Yu
Journal:  Mol Med Rep       Date:  2016-08-09       Impact factor: 2.952

9.  Frontocingulate Dysfunction Is Associated with Depression and Decreased Serum PON1 in Methamphetamine-Dependent Patients.

Authors:  Nooshin Ghavidel; Fariba Khodagholi; Abolhassan Ahmadiani; Reza Khosrowabadi; Sareh Asadi; Jamal Shams
Journal:  Neuropsychiatr Dis Treat       Date:  2020-02-19       Impact factor: 2.570

10.  Arylesterase Activity of Paraoxonase-1 in Serum and Cerebrospinal Fluid of Patients with Alzheimer's Disease and Vascular Dementia.

Authors:  Arianna Romani; Alessandro Trentini; Wiesje M van der Flier; Tiziana Bellini; Giovanni Zuliani; Carlo Cervellati; Charlotte E Teunissen
Journal:  Antioxidants (Basel)       Date:  2020-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.